openPR Logo
Press release

World conference on STDs, STIs & HIV/AIDS

12-30-2016 09:31 AM CET | Science & Education

Press release from: Allied academies

"World Conference on STDs, STIs & HIV/AIDS is a leading Conference in Canada, the program will explore new scientific knowledge and provides a platform for professionals and community members to participate in a structured dialogue on the major issues. The main objective will be to share scientific discoveries and clinical care on HIV and STDs, HIV diagnosis and therapy that would comprise various methods to diagnose HIV, HIV drug discovery, viral and bacterial STDs, STIs, like Herpes, HPV etc., strategies for HIV and STDs prevention, bioethics etc. As HIV/AIDS is an alarming concern throughout the world, STDs & HIV/AIDS-2017 will mainly focus on issues like Primary HIV Infection, Transmission and Eradication Issues apart from this,The genetic approaches towards prevention of HIV & STDs, HIV Co-infection, HIV ongoing pharmaceutical design would cover the experimental drugs developed. STDs & HIV/AIDS-2017, lays perfect platform for Medical professionals, physicians, nurse-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Academicians who are working in the field of HIV & STDs medicine.

Join us in Vancouver,Canada for the Worlds leading conference event."

Allied academies conferences

154 Chestnut Creek Road
Candler, NC 28715, USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release World conference on STDs, STIs & HIV/AIDS here

News-ID: 403062 • Views: 346

More Releases from Allied academies

2nd International Conference on Plant Science
We would like to welcome all to our 2nd International Conference on Plant Science in Prague, Czech Republic, September 23 - 24, 2019 under the theme "Plant Hindrances and Outcomes". Please Science 2019 webpage: http://plantscience.alliedacademies.com/ Plant Science 2019 aims to unite all the research scholars, Industrialists, Academicians, Pedologists, Agronomists, Geologist, Plantation Companies and Agricultural Consultants, to take part in workshops, symposiums, video, and poster presentations and exhibition on the developments in current
CPD Accredited 3rd International Conference on Wound Care, Tissue Repair and Reg …
Wound Care 2019 Back again! To fame the past, cherish the present and mould the future of Wound Care, Tissue Repair and Regenerative Medicine in association/collaboration with Balkan Wound Management Association (BALWMA) on September 09-10, 2019 at Edinburgh, Scotland. Wound Care Congress 2019 gives access to global experts and researchers in unique platform and make every connection matter. "The live format of this educational activity will be accredited with CME and
Emerging Innovations in Dermatology and Trichology
Dermatology is a field of medicine that deals with diseases and treatments associated with skin, hair and nails, sometimes also cosmetic care and enhancement. It is concerned with all the disorders of outer skin and Inner mucous membrane. It’s having a specialty of both surgical and medical aspects; the skin is the largest and most visible organ of our body. It reflects the health of the body and act as
2nd International Conference on Surgery and Surgical Nursing
The Surgery 2019 team is delighted to announce the 2nd International Conference on Surgery and Surgical Nursing (Surgery 2019), which will be held in London, United Kingdom., on March 11-12, 2018. Among the growing list of keynote speakers are experts in surgery and nursing, distinguished professors, policy makers and representatives from across the globe. The theme for Surgery 2019 is "Exploring the tailored approach and future of Surgery" We are excited

All 5 Releases


More Releases for HIV

Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral